This is a randomized trial for after all neo or adjuvant therapy is complete for women are Her2 1+ or HER2 2+

Clinical Program: Breast Cancer Program
Cancer Type & Condition: Breast Cancer
Primary Sponsor: Departmental
Contact Info: 202-677-6828